LON:OPTI OptiBiotix Health (OPTI) Share Price, News & Analysis GBX 15.10 +0.10 (+0.67%) As of 04:59 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsHeadlinesBuy This Stock About OptiBiotix Health Stock (LON:OPTI) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get OptiBiotix Health alerts:Sign Up Key Stats Today's Range 14.75▼ 15.5050-Day Range 14.80▼ 20.7852-Week Range 10▼ 35Volume86,335 shsAverage Volume290,095 shsMarket Capitalization£14.79 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewOptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness. OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks. OptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, cardiovascular health, and diabetes. This communication is a "Reach" announcement. Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained in this announcement is of a non-regulatory nature. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on RNS Reach.Read More… Receive OPTI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for OptiBiotix Health and its competitors with MarketBeat's FREE daily newsletter. Email Address OPTI Stock News HeadlinesOptiBiotix Health (LON:OPTI) Shares Down 12.3% - Time to Sell?May 25 at 1:56 AM | americanbankingnews.comYork biotech company appoints new finance directorJanuary 17, 2025 | msn.comJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are already using to their advantage… It allows them to treat this new asset like actual cash.May 28, 2025 | Premier Gold Co (Ad)Undervalued Opportunities UK Penny Stocks To Watch In December 2024December 6, 2024 | uk.finance.yahoo.comOptiBiotix Health Share Chat (OPTI)November 1, 2024 | lse.co.ukOptiBiotix Health Updates Shareholders on Voting RightsOctober 24, 2024 | msn.comTRADING UPDATES: LMS Capital NAV falls; Cloudcoco sells unitOctober 19, 2024 | lse.co.ukOptibiotix Health PLC (OPTIO)October 3, 2024 | investing.comSee More Headlines OPTI Stock Analysis - Frequently Asked Questions How have OPTI shares performed this year? OptiBiotix Health's stock was trading at GBX 18.05 at the start of the year. Since then, OPTI stock has decreased by 16.3% and is now trading at GBX 15.10. View the best growth stocks for 2025 here. How were OptiBiotix Health's earnings last quarter? OptiBiotix Health Plc (LON:OPTI) posted its quarterly earnings results on Thursday, September, 24th. The company reported ($0.70) earnings per share for the quarter. OptiBiotix Health had a negative net margin of 524.43% and a negative trailing twelve-month return on equity of 36.76%. How do I buy shares of OptiBiotix Health? Shares of OPTI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of OptiBiotix Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that OptiBiotix Health investors own include SkinBioTherapeutics (SBTX), IQE (IQE), Oracle (ORCL), Digital Globe Services (DGS), Derwent London (DLN), Petrofac (PFC) and IP Group (IPO). Company Calendar Last Earnings9/24/2020Today5/28/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryPharmaceutical Products Current SymbolLON:OPTI Previous SymbolLON:CMI CIKN/A Webwww.optibiotix.com Phone+44-20-79338780FaxN/AEmployees1Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (3.16) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-£3.09 million Net Margins-524.43% Pretax MarginN/A Return on Equity-36.76% Return on Assets-13.93% Debt Debt-to-Equity RatioN/A Current Ratio6.18 Quick Ratio7.89 Sales & Book Value Annual Sales£590,009.23 Price / Sales25.07 Cash FlowGBX 1.74 per share Price / Cash Flow8.68 Book ValueGBX 7.80 per share Price / Book1.94Miscellaneous Outstanding Shares97,943,197Free FloatN/AMarket Cap£14.79 million OptionableNot Optionable Beta1.71 The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free Report This page (LON:OPTI) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredDo You Believe In President Trump? Answer This 1 QuestionThey said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OptiBiotix Health Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share OptiBiotix Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.